Cargando…
Current clinical understanding and effectiveness of portopulmonary hypertension treatment
Portopulmonary hypertension (PoPH) is a rare subtype of Group 1 pulmonary arterial hypertension (PAH) with a poor prognosis. According to the most up-to-date definition, PoPH is characterized by a mean pulmonary arterial pressure (PAP) of >20 mmHg at rest, a pulmonary artery wedge pressure of ≤15...
Autores principales: | Tamura, Yuichi, Tamura, Yudai, Taniguchi, Yu, Atsukawa, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110923/ https://www.ncbi.nlm.nih.gov/pubmed/37081835 http://dx.doi.org/10.3389/fmed.2023.1142836 |
Ejemplares similares
-
How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis
por: Atsukawa, Masanori, et al.
Publicado: (2023) -
Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan
por: Atsukawa, Masanori, et al.
Publicado: (2022) -
Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry
por: Tamura, Yudai, et al.
Publicado: (2022) -
Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020) -
Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010)